These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20884214)

  • 1. Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration.
    Sallam AA; Ramasahayam S; Meyer SA; El Sayed KA
    Bioorg Med Chem; 2010 Nov; 18(21):7446-57. PubMed ID: 20884214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of semisynthetic analogues and 3D-QSAR study of eunicellin-based diterpenoids as prostate cancer migration and invasion inhibitors.
    Hassan HM; Elnagar AY; Khanfar MA; Sallam AA; Mohammed R; Shaala LA; Youssef DT; Hifnawy MS; El Sayed KA
    Eur J Med Chem; 2011 Apr; 46(4):1122-30. PubMed ID: 21334794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships study of bastadin 6, an anti-angiogenic brominated-tyrosine derived metabolite from marine sponge.
    Kotoku N; Hiramatsu A; Tsujita H; Hirakawa Y; Sanagawa M; Aoki S; Kobayashi M
    Arch Pharm (Weinheim); 2008 Sep; 341(9):568-77. PubMed ID: 18763716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
    La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
    J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
    Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
    Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pyrazole derivatives: synthesis and evaluation of anti-angiogenic activity.
    Christodoulou MS; Liekens S; Kasiotis KM; Haroutounian SA
    Bioorg Med Chem; 2010 Jun; 18(12):4338-50. PubMed ID: 20493716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
    An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
    Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor cell invasion and angiogenesis by motuporamines.
    Roskelley CD; Williams DE; McHardy LM; Leong KG; Troussard A; Karsan A; Andersen RJ; Dedhar S; Roberge M
    Cancer Res; 2001 Sep; 61(18):6788-94. PubMed ID: 11559552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
    Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
    J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo.
    Lirdprapamongkol K; Kramb JP; Chokchaichamnankit D; Srisomsap C; Surarit R; Sila-Asna M; Bunyaratvej A; Dannhardt G; Svasti J
    In Vivo; 2008; 22(3):363-8. PubMed ID: 18610749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
    Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
    J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    Isaacs JT; Pili R; Qian DZ; Dalrymple SL; Garrison JB; Kyprianou N; Björk A; Olsson A; Leanderson T
    Prostate; 2006 Dec; 66(16):1768-78. PubMed ID: 16955399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
    Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.